MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with D

Doxycycline

Doxycycline 20mg tablets

Use with caution

Stability notes for Doxycycline 20mg tablets

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Periostat 20mg tablets (Alliance Pharmaceuticals Ltd).

Supplier

Periostat 20mg tablets (Universal Medicines Ltd)

Doxycycline 40mg modified-release capsules

Use with caution

Stability notes for Doxycycline 40mg modified-release capsules

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Efracea 40mg modified-release capsules (Galderma (UK) Ltd).

Supplier

Efracea 40mg modified-release capsules (Galderma (UK) Ltd)

Doxycycline 50mg capsules

Use with caution

Stability notes for Doxycycline 50mg capsules

Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Doxycycline 50mg capsules (Kent Pharma (UK) Ltd).

Suppliers (9) of Doxycycline 50mg capsules
Doxycycline 50mg capsules (A A H Pharmaceuticals Ltd)
Doxycycline 50mg capsules (Accord-UK Ltd)
Doxycycline 50mg capsules (Alliance Healthcare (Distribution) Ltd)
Doxycycline 50mg capsules (Almus Pharmaceuticals Ltd)
Doxycycline 50mg capsules (Drugsrus Ltd)
Doxycycline 50mg capsules (Medihealth (Northern) Ltd)
Doxycycline 50mg capsules (Phoenix Healthcare Distribution Ltd)
Doxycycline 50mg capsules (Sigma Pharmaceuticals Plc)
Doxycycline 50mg capsules (Sovereign Medical Ltd)

Doxycycline 100mg capsules

Use with caution

Stability notes for Doxycycline 100mg capsules

Protect from light and store in an airtight container. Maximum 7 days in MCA.

Provenance

This compatibility recommendation is derived from Doxycycline 100mg capsules (Kent Pharma (UK) Ltd).

Suppliers (13) of Doxycycline 100mg capsules
Doxycycline 100mg capsules (A A H Pharmaceuticals Ltd)
Doxycycline 100mg capsules (Accord-UK Ltd)
Doxycycline 100mg capsules (Alliance Healthcare (Distribution) Ltd)
Doxycycline 100mg capsules (Almus Pharmaceuticals Ltd)
Doxycycline 100mg capsules (Drugsrus Ltd)
Doxycycline 100mg capsules (Genesis Pharmaceuticals Ltd)
Doxycycline 100mg capsules (Healthcare Pharma Ltd)
Doxycycline 100mg capsules (Kent Pharma (UK) Ltd)
Doxycycline 100mg capsules (Medihealth (Northern) Ltd)
Doxycycline 100mg capsules (Phoenix Healthcare Distribution Ltd)
Doxycycline 100mg capsules (Sigma Pharmaceuticals Plc)
Doxycycline 100mg capsules (Sovereign Medical Ltd)
Doxycycline 100mg capsules (Teva UK Ltd)

Doxycycline 100mg dispersible tablets sugar free

No stability information

Stability notes for Doxycycline 100mg dispersible tablets sugar free

There are no stability notes for this medicine.

Suppliers

Doxycycline 100mg dispersible tablets sugar free (Drugsrus Ltd)
Vibramycin-D 100mg dispersible tablets (Pfizer Ltd)
Vibramycin-D 100mg dispersible tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.